Delivery Order SPE2DB22D3102-SPE2DB25FL3BT
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Pediarix 0.5 ML syringes, a pediatric combination vaccine. This firm fixed price delivery order, valued at $1,252.15, carries an ultimate completion date of September 17, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting the contractor's demonstrated...
- The Defense Logistics Agency awarded a delivery order valued at $5,331.52 to AmerisourceBergen Drug Corp for Pediarix 0.5 mL syringes on September 12, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price delivery order represents a pediatric vaccination product sourced from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract involves no set-aside designation and is executed under a larger indefinite...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,276.61 on August 8, 2025, for the supply of Pediarix 0.5 ML syringes. This non-competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of August 11, 2025, with performance to be executed at the vendor's facility in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under AmerisourceBergen's broader contractual...
- The Defense Logistics Agency awarded a delivery order valued at $4,206.10 to AmerisourceBergen Drug Corp for Pediarix 0.5 ML syringes on November 26, 2025, with an ultimate completion date of November 28, 2025. This contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This...
- The Defense Logistics Agency awarded a $15,276.35 delivery order to AmerisourceBergen Drug Corp for Pediarix 0.5 ML syringes on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price contract represents a single delivery of the pediatric vaccine product to support federal medical procurement needs. The award is not associated with a set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a $5,450.13 delivery order to AmerisourceBergen Drug Corp for Pediarix 0.5 ML syringes on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's significant Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,759.00 to AmerisourceBergen Drug Corp for the supply of Pediarix 0.5 ml syringes. This competitively awarded, firm fixed-price delivery order was issued on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Pediarix is a pediatric combination vaccine, and this order represents one of numerous pharmaceutical...
- The Defense Logistics Agency awarded a $8,259.00 delivery order to AmerisourceBergen Drug Corp for Pediarix 0.5 ML syringes on November 6, 2025, with completion scheduled for November 7, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The contract involves no set-aside designation and specifies...
- The Defense Logistics Agency awarded a delivery order valued at $2,920.27 to AmerisourceBergen Drug Corp for Pediarix 0.5 mL syringes on July 24, 2025, with completion scheduled for July 25, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a single delivery of the pediatric vaccine product to support federal medical supply requirements. The contract is performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company operates as a major...
- The Defense Logistics Agency awarded a delivery order valued at $9,050.58 to AmerisourceBergen Drug Corp for the supply of Pediarix 0.5 ML syringes, with a completion deadline of December 10, 2025. This competitively awarded, firm fixed-price contract represents a pediatric vaccine delivery to support military healthcare requirements. The award was issued on December 9, 2025, with performance to be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FL3BTDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,166.15 to AmerisourceBergen Drug Corp for Pediarix 0.5 mL syringes on September 17, 2025, with an ultimate completion date of September 18, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location and will deliver the vaccine product to support federal medical procurement needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive IDC serves as the primary pharmaceutical supply vehicle for military healthcare programs globally, enabling the company to deliver vaccines, medications, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The arrangement supports critical medical supply operations for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, positioning AmerisourceBergen Drug Corp as a key vendor within the DLA's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 9/17/25 |